查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1440015

聚合酶鍊式反應 (PCR) - 全球市場考量、競爭格局、市場預測 (2030)

Polymerase Chain Reaction - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球聚合酶連鎖反應（PCR）市場規模預計到2023年將達到49億美元，到2030年將達到80.4億美元，2024-2030年預測期間複合年增長率為8.66%。由於病原體引起的疾病盛行率上升、臨床診斷領域的利用率不斷提高以及新技術的進步進一步提高其準確性等因素，預計該市場的收入將增加，並且預測該市場預計將產生顯著的收入期間（2024-2030）收入成長。

聚合酶鍊式反應 (PCR) 市場動態

聚合酶鍊式反應 (PCR) 市場的顯著驅動因素之一是 PCR 技術在臨床診斷領域的使用不斷增加。事實證明，使用即時 RT-PCR 技術作為檢測 COVID-19 大流行中是否存在 SARS-CoV 的方法對醫療產業有益。根據世界衛生組織（2019）的說法，RT-PCR 是檢測 SARSCOVID-19 的黃金標準。例如，根據世界衛生組織（2023）的報告，全球有 540,923,532 例確診的 COVID-19 病例，所有病例都是透過 RT-PCR 檢測發現的。使用 RT-PCR 方法的主要原因是其高靈敏度和特異性。RT-PCR方法不僅適用於COVID-19的檢測，也用於腫瘤學中癌細胞的檢測。例如，根據Annals of Surgery（2019），RT-PCR 是觀察大腸直腸癌病例中循環癌細胞的最有效方法。

推動聚合酶鍊式反應 (PCR) 市場成長的其他主要因素之一是其在遺傳性疾病診斷中的使用不斷增加。例如，根據Swedish Agency for Health Technology Assessment and Assessment of Social Services（2019）的數據，RT-PCR 在 80% 疑似遺傳性疾病的病例中取代了大多數傳統診斷方法。推動聚合酶鍊式反應 (PCR) 市場成長的另一個主要因素是 PCR 技術的不斷進步，以提高產品的功效。例如，2020 年 12 月，Stilla Technologies 推出了Polymerase Chain Reaction Mix試劑系列，以實現Crystal Digital PCR（nacia multiplex PCR Mix、nacia PCR Mix）的最佳性能。它們經過優化，可在數位 PCR 應用中實現卓越的結果和穩健性。

在類似的開發中，DNA/RNA 分析專家 PCR Biosystems 於 2022 年 3 月推出了IsoFast Bst Polymerase套裝，用於快速、穩健的 DNA 和 RNA 擴增。然而，替代療法的可用性以及聚合酶鏈反應（PCR）設備和試劑的高成本可能成為聚合酶鏈反應（PCR）市場成長的限制因素。

由於 COVID-19 大流行，聚合酶鏈反應 (PCR) 市場經歷了一段市場快速增長期。COVID-19大流行導致衛生服務和醫療程序的實施發生重大重組，根據世界衛生組織（2019）的說法，RT-PCR檢測報告成為感染檢測的標準。在 COVID-19 階段，參與聚合酶鏈反應 (PCR) 市場的所有主要市場參與者的收入都經歷了強勁增長。例如，根Thermo Fisher Scientific Corporation年報（2023），該公司營收佔有率較2018年成長26%至322.2億美元，GAAP攤薄後每股收益成長74%。又如，根據Qiagen Annual Report（2023 年），Qiagen 的收入佔有率較 2018 年飆升 22.53%。儘管全球範圍內的COVID-19 患者數量正在減少，但基於聚合酶鏈反應(PCR) 的檢測在臨床診斷和研究中的某些應用仍在增加，並將在2024-2030 年的預測期內繼續成長。聚合酶鍊式反應 (PCR) 市場的成長。

本報告提供了全球聚合酶鍊式反應 (PCR) 市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第一章聚合酶連鎖反應（PCR）市場報告簡介

第二章聚合酶鍊式反應 (PCR) 市場執行摘要

  • 調查範圍
  • 市場概況
  • 競爭評估
  • 財務基準

第三章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章聚合酶連鎖反應（PCR）市場關鍵因素分析

  • 聚合酶鍊式反應 (PCR) 市場的驅動因素
  • 聚合酶鍊式反應（PCR）市場的限制與挑戰
  • 聚合酶鍊式反應 (PCR) 市場機會

第五章聚合酶鍊式反應（PCR）市場的波特五力分析

第六章 COVID-19對聚合酶鍊式反應（PCR）市場的影響分析

第七章 聚合酶鍊式反應（PCR）市場佈局

  • 依類型
    • 常規PCR
    • 實時RT-PCR
    • 數位PCR
    • 其他
  • 依用途
    • 感染
    • 癌症
    • 遺傳病
  • 依最終用戶
    • 醫院、診所
    • 學術/研究所
  • 區域
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第八章聚合酶鍊式反應 (PCR) 市場：全球公司佔有率分析 - 3 至 5 家主要公司

第 9 章聚合酶鍊式反應 (PCR) 市場公司與產品概況

  • Thermo-Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Qiagen
  • Agilent Technologies, Inc.
  • Standard Biotools
  • F. Hoffmann-La Roche Ltd.
  • Eppendorf
  • Avance Biosciences Inc.
  • Merck & Co., Inc.
  • Abbott
  • Promega Corporation
  • Takara Bio Inc.
  • Endress+Hauser Group Services AG
  • BioMerieux
  • GenMark Diagnostics, Inc.
  • Grifols, S.A
  • Hologic, Inc.
  • BD
  • Sysmex Corporation
  • Stilla

第10章 KOL觀點

第11章 專案方法

第 12 章. 關於 DelveInsight

第十三章 免責聲明與聯絡我們

Product Code: DISR0053

Polymerase Chain Reaction Market By Type (Conventional PCR, Real-Time RT-PCR, Digital PCR, Others) By Application (Infectious Diseases, Cancer, Hereditary Disorders, And Others), By End-User (Hospitals & Clinics, Academic & Research Labs, Others) and by geography is estimated to register growth at a remarkable CAGR forecast during 2024-2030 owing to rise in the prevalence of infectious diseases, increased applications in clinical diagnostics, and constant advancements in pcr technology for efficient use in biomedical sciences.

The Global Polymerase Chain Reaction market was valued at USD 4.90 billion in 2023, growing at a CAGR of 8.66% during the forecast period from 2024 to 2030 to reach USD 8.04 billion by 2030. The Polymerase Chain Reaction market is slated to witness increasing revenue owing to factors such as a rise in the prevalence of diseases caused by pathogens, increasing applications in the field of clinical diagnostics, along with latest technological advancements to further enhance its accuracy is expected to result in appreciable revenue growth in the Polymerase Chain Reaction market during the forecast period (2024-2030).

Polymerase Chain Reaction Market Dynamics:

One of the noteworthy drivers of the Polymerase Chain Reaction market is the increasing use of PCR techniques in the clinical diagnostics sector. The use of the real-time RT-PCR technique as a way to detect the presence of SARS-CoV during the COVID-19 pandemic has proved to be a boon for the healthcare industry. According to the World Health Organization (2019), the RT-PCR technique is the golden standard for the detection of SARS coronavirus. For instance, as per reports from World Health Organization (2023), there have been 540,923,532 confirmed cases of Covid-19 worldwide, and every case was detected through the use of an RT-PCR test. The main reasons associated with the use of the RT-PCR technique are its high sensitivity and specificity. Not only is the RT-PCR solely applicable for the detection of COVID-19, but it is also used in oncology for the detection of cancer cells. For example, according to the Annals of Surgery (2019), RT-PCR was the most effective technique for the observation of circulating cancer cells in cases of colorectal cancer.

One of the other prominent factors responsible for the growth of the Polymerase Chain Reaction Market is its increasing use in the diagnosis of genetic disorders. For example, according to the Swedish Agency for Health Technology Assessment and Assessment of Social Services (2019), the RT-PCR technique has replaced most of the conventional diagnostic methods in 80% of suspected cases of genetic disorders. Another key factor responsible for the growth of the Polymerase Chain Reaction market is the continuous technological advancements taking place in PCR technology to improve product efficacy. For instance, in December 2020, Stilla Technologies launched a Polymerase Chain Reaction Mix reagent line for optimal performance with Crystal Digital PCR (nacia multiplex PCR Mix and nacia PCR Mix), which are optimized for better results and robustness for digital PCR applications.

In a similar development, in March 2022, PCR Biosystems, specialists in DNA and RNA analysis launched a set of IsoFast Bst Polymerase reagents for rapid, robust DNA & RNA amplification. However, the availability of alternative therapies and the high cost of the Polymerase Chain Reaction machine and reagents may act as restraining factors to the Polymerase Chain Reaction market growth.

The Polymerase Chain Reaction market reported a period of rapid market growth due to the COVID-19 pandemic. The COVID-19 pandemic resulted in the massive reorganization of the healthcare services and carrying out of medical procedures, where the RT-PCR test reports were the measure for the detection of infection, as per the World Health Organization (2019). All the key market players involved in the Polymerase Chain Reaction Market experienced robust growth in their revenue during the phases of COVID-19. For example, according to the annual report of Thermo Fisher Scientific Corporation (2023), the revenue share of the company increased by 26% to 32.22 billion USD, and the GAAP diluted EPS increased by 74%, as compared to 2018. In another instance, according to the Qiagen Annual Report (2023), Qiagen saw a jump in its revenue share by 22.53% as compared to 2018. Although the global COVID-19 cases reducing, still Polymerase Chain Reaction based test is on the rise because of their constant applications in clinical diagnostics and research, which is uplifting the Polymerase Chain Reaction market growth during the forecast period from 2024-2030.

Polymerase Chain Reaction Market Segment Analysis:

Polymerase Chain Reaction Market by Type (Conventional PCR, Real-time RT-PCR, Digital PCR, and Others), Application (Infectious diseases, Cancer, Hereditary disorders, and Others), End-user (Hospitals & Clinics, Academic & Research Labs, Others), Geography (North-America, Europe, Asia-Pacific, Rest of the World)

Based on the Application segment of the Polymerase Chain Reaction Market, the infectious diseases category is projected to register significant growth in revenue in the Polymerase Chain Reaction market during the forecast period (2024-2030). This can be ascribed to the increasing prevalence of infectious diseases caused by viruses, bacteria, fungi, and other pathogens. With one of the most infectious and recent examples of infectious disease being COVID-19, other hazardous diseases caused by pathogens are HIV AIDS, and Tuberculosis, caused by viruses and bacteria respectively. As per reports from World Health Organization (2023), there were 37.7 billion cases of HIV-AIDS globally, by the end of 2020.

The RT-PCR technique is regarded as the alternative gold standard for the detection of HIV AIDS. In cases of bacterial infection diseases like Tuberculosis, the RT-PCR technique shows high sensitivity and specificity during diagnosis. The RT-PCR technique also has its advantages in oncological studies. As per reports from World Health Organization (2023) cancer accounted for approximately 10 million deaths, in the year 2020. According to the same source, one of the primary reasons for cancer deaths was the late diagnosis of the disease, to which the Polymerase Chain Reaction appears to be the fastest and most sensitive test for the detection of tumors.

Therefore, considering the growing demand for this product type, numerous new products are being launched in the market with technological advancements. For example, in March 2022, MatMa Corporation launched MYRTA, a new hand-held Real-Time RT-PCR device for Point-of-Care (POC) and Over-the-Counter (OTC) molecular diagnostics.

Thus, considering the rising prevalence of various infectious diseases and their growing popularity among end users, the application segment is expected to generate considerable revenue thereby pushing the overall growth of the global Polymerase Chain Reaction market during the forecast period.

North America is expected to dominate the overall Polymerase Chain Reaction Market:

Among all the regions, North America is expected to lead in revenue generation in the global Polymerase Chain Reaction market. This can be ascribed to the growing prevalence of infectious diseases and the increasing number of clinical research studies in the North American region. According to the Centre for Disease Prevention and Control (2023), 6 in 10 people in the United States were burdened with a chronic disease, and 4 in 10 people had two or more diseases in the year 2023. The World Health Organization (2023) statistics show that the COVID-19 pandemic has severly impacted the U.S., with 88,932,987 cases and 1,018,035 deaths, by July 14, 2022. Due to such a high prevalence of infectious diseases in the United States, it expands the way for more amount of clinical studies and the latest diagnostic technological developments.

One of the other prominent factors supporting the growth of the North America Polymerase Chain Reaction market is the rising case of genetic disorders in the North American region. As per reports from the Centre for Disease Control and Prevention (2023), millions of people are affected by inherited genetic disorders such as cystic fibrosis, sickle-cell anemia, Lynch syndrome, etc. every year. Some genetic disorders are not diagnosed at birth but lead to severe consequences at a later stage due to late detection of the syndrome. For example, the report from the World Health Organization, Regional Office for the Eastern Mediterranean (2023), shows that cases with genetic disorders account for 2%-5% of all live births, 30% of the affected account for hospital admissions at a later stage, and 50% account for deaths during childhood in the year 2020, in industrialized countries.

The presence of a large patient population base in the North American region, also opens up the way for new technologies and collaborations to take place in clinical diagnostics areas. For example, in June 2022, Bio-Rad collaborated with Seegene Inc. for the production of molecular diagnostic products related to infectious diseases. Through this collaboration, Seegene started to provide diagnostic tests for use on Bio-Rad's LFX960x Real-Time PCR System for commercial use in the U.S. market. In another instance, according to the American Chemical Society (2023), researchers devised a postage stamp-sized polydimethylsiloxane chip with microchambers arrays in the PCR. Although the amplification efficiency of the chip-encoded PCR was 91% as compared to 98% in standard PCR, the chip-encoded PCR takes approximately 5 minutes for detection as compared to an hour in conventional PCRs. The source further stated that the technique will get commercialized in the future and could be used for rapid detection diagnosis during severe cases of pandemics.

Therefore, the presence of a large patient population base with infectious diseases and genetic disorders, coupled with a rise in technological advancements and clinical research studies is expected to bolster the growth of the Polymerase Chain Reaction market in the North American region during the forecast period.

Polymerase Chain Reaction Market Key Players:

Some of the key market players operating in the Polymerase Chain Reaction market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen, Agilent Technologies Inc., Standard Biotools, F. Hoffmann-La Roche Ltd., Eppendorf, Avance Biosciences Inc., Merck & Co. Inc., Abbott, Promega Corporation, Takara Bio Inc., Endress+Hauser Group Services AG, BioMerieux, GenMark Diagnostics Inc., Grifols SA, Hologic Inc., BD, Sysmex Corporation, Stilla, and others.

Recent Developmental Activities in the Polymerase Chain Reaction Market:

In January 2022, Qiagen collaborated with Atila Biosystems and Actome GmbH for the use of QIAcuity digital PCR instruments. Atila Biosystems will provide non-invasive prenatal testing and Actome extends QIAcuity reach from genomics to proteomics.

In June 2022, Bio-Rad collaborated with Seegene Inc., for the production of molecular diagnostic products related to infectious diseases. Through this, Seegene shall provide diagnostic tests in U.S markets for use on Bio-Rad's LFX960x real-time PCR system.

In March 2022, MatMa Corporation launched MYRTA, a new hand-held PCR device for POC & OTC Molecular Diagnostics.

Key Takeaways from the Polymerase Chain Reaction Market Report Study

  • Market size analysis for current Polymerase Chain Reaction market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the polymerase chain reaction market.
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, joint ventures happened for last 3 years.
  • Key companies dominating the global Polymerase Chain Reaction market.
  • Various opportunities available for the other competitor in the Polymerase Chain Reaction market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Polymerase Chain Reaction market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Polymerase Chain Reaction market growth in the coming future?

Target Audience who can be benefited from this Polymerase Chain Reaction Market Report Study

  • Polymerase Chain Reaction providers
  • Research organizations and consulting companies
  • Polymerase Chain Reaction -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Polymerase Chain Reaction machines and reagents
  • Various end users who want to know more about the Polymerase Chain Reaction market and latest technological developments in the Polymerase Chain Reaction market.

Frequently Asked Questions for Polymerase Chain Reaction Market:

1. What is Polymerase Chain Reaction?

Polymerase Chain Reaction is a laboratory technique based on the enzymatic replication of DNA. Short strands of DNA are amplified using enzymes that are primer-mediated. Through this, million to billion copies of DNA can be produced, leading to better observation and conduct of research studies.

2. What is the market for Global Polymerase Chain Reaction?

The Global Polymerase Chain Reaction market was valued at USD 4.90 billion in 2023, growing at a CAGR of 8.66% during the forecast period from 2024 to 2030 to reach USD 8.04 billion by 2030.

3. What are the drivers for Global Polymerase Chain Reaction market?

The Polymerase Chain Reaction Market is expected to grow significantly owing to factors such as a rise in the prevalence of diseases caused by pathogens and increasing applications in the field of clinical diagnostics. The rapidly growing technological advancements taking place in the Polymerase Chain Reaction market with better technologies for delivering precise results in a quick time are further expected to result in appreciable revenue growth in the Polymerase Chain Reaction market during the given forecast period (2024-2030).

4. Who are the key players operating in the Global Polymerase Chain Reaction Market?

Some of the key market players operating in the Polymerase Chain Reaction market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen, Agilent Technologies Inc., Standard Biotools, F. Hoffmann-La Roche Ltd., Eppendorf, Avance Biosciences Inc., Merck & Co. Inc., Abbott, Promega Corporation, Takara Bio Inc., Endress+Hauser Group Services AG, BioMerieux, GenMark Diagnostics Inc., Grifols SA, Hologic Inc., BD, Sysmex Corporation, Stilla, and others.

5. Which region has the highest share in the Polymerase Chain Reaction market?

North America is expected to dominate the overall Polymerase Chain Reaction market during the forecast period, 2024 to 2030. This can be ascribed to the presence of a huge number of cases of infectious diseases and genetic disorders in the North American region, leading to more diagnostic procedures. In addition, it is a highly potent market in terms of technological developments and new product launches along with the presence of key market players among other factors in the region.

Table of Contents

1.Polymerase Chain Reaction Market Report Introduction

2.Polymerase Chain Reaction Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Polymerase Chain Reaction Market Key Factors Analysis

  • 4.1. Polymerase Chain Reaction Market Drivers
    • 4.1.1. Rising demand for clinical diagnostics
    • 4.1.2. Increased applications in drug development and medicine
    • 4.1.3. Advancements in PCR Technology for more precise results
  • 4.2. Polymerase Chain Reaction Market Restraints and Challenges
    • 4.2.1. High cost of PCR machines
    • 4.2.2. Alternatives to PCR technology
  • 4.3. Polymerase Chain Reaction Market Opportunities
    • 4.3.1. Improving Product Technology and accuracy

5. Polymerase Chain Reaction Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Polymerase Chain Reaction Market

7. Polymerase Chain Reaction Market Layout

  • 7.1. By Type:
    • 7.1.1. Conventional PCR
    • 7.1.2. Real-time RT-PCR
    • 7.1.3. Digital PCR
    • 7.1.4. Others
  • 7.2. By Application:
    • 7.2.1. Infectious Diseases
    • 7.2.2. Cancer
    • 7.2.3. Hereditary Disorders
    • 7.2.4. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals and Clinics
    • 7.3.2. Academic & Research Labs
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.1.2. Canada Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.1.3. Mexico Polymerase Chain Reaction Market in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.2.2. Germany Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.2.4. Italy Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.2.5. Spain Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.2.6. Russia Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.2.7. Rest of Europe Polymerase Chain Reaction Market in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.3.2. Japan Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.3.3. India Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.3.4. Australia Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.3.5. South Korea Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia Pacific Polymerase Chain Reaction Market in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.4.2 Africa Polymerase Chain Reaction Market in USD million (2021-2030)
      • 7.4.4.3 South America Polymerase Chain Reaction Market in USD million (2021-2030)

8. Polymerase Chain Reaction Market Global Company Share Analysis - Key 3-5 Companies

9. Polymerase Chain Reaction Market Company and Product Profiles

  • 9.1. Thermo-Fisher Scientific Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Bio-Rad Laboratories, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Qiagen
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Agilent Technologies, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Standard Biotools
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. F. Hoffmann-La Roche Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Eppendorf
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Avance Biosciences Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Merck & Co., Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Abbott
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Promega Corporation
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Takara Bio Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Endress+Hauser Group Services AG
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. BioMerieux
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. GenMark Diagnostics, Inc.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Grifols, S.A
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Hologic, Inc.
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. BD
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Sysmex Corporation
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Stilla
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Polymerase Chain Reaction Market
  • Table 3: Polymerase Chain Reaction Market in Global (2021-2030)
  • Table 4: Polymerase Chain Reaction Market in Global by Type (2021-2030)
  • Table 5: Polymerase Chain Reaction Market in Global by Application(2021-2030)
  • Table 6: Polymerase Chain Reaction Market in Global by End User (2021-2030)
  • Table 7: Polymerase Chain Reaction Market in Global by Geography (2021-2030)
  • Table 8: Polymerase Chain Reaction Market in North America (2021-2030)
  • Table 9: Polymerase Chain Reaction Market in North America by Country (2021-2030)
  • Table 10: Polymerase Chain Reaction Market in the US (2021-2030)
  • Table 11: Polymerase Chain Reaction Market in Canada (2021-2030)
  • Table 12: Polymerase Chain Reaction Market in Mexico (2021-2030)
  • Table 13: Polymerase Chain Reaction Market in Europe (2021-2030)
  • Table 14: Polymerase Chain Reaction Market in Europe by Country (2021-2030)
  • Table 15: Polymerase Chain Reaction Market in France (2021-2030)
  • Table 16: Polymerase Chain Reaction Market in Germany (2021-2030)
  • Table 17: Polymerase Chain Reaction Market in the United Kingdom (2021-2030)
  • Table 18: Polymerase Chain Reaction Market in Italy (2021-2030)
  • Table 19: Polymerase Chain Reaction Market in Spain (2021-2030)
  • Table 20: Polymerase Chain Reaction Market in Russia (2021-2030)
  • Table 21: Polymerase Chain Reaction Market in Rest of Europe (2021-2030)
  • Table 22: Polymerase Chain Reaction Market in APAC (2021-2030)
  • Table 23: Polymerase Chain Reaction Market in APAC by Country (2021-2030)
  • Table 24: Polymerase Chain Reaction Market in China (2021-2030)
  • Table 25: Polymerase Chain Reaction Market in Japan (2021-2030)
  • Table 26: Polymerase Chain Reaction Market in India (2021-2030)
  • Table 27: Polymerase Chain Reaction Market in Australia (2021-2030)
  • Table 28: Polymerase Chain Reaction Market in South Korea (2021-2030)
  • Table 29: Polymerase Chain Reaction Market in Rest of APAC (2021-2030)
  • Table 30: Polymerase Chain Reaction Market in Rest of World (2021-2030)
  • Table 31: Polymerase Chain Reaction Market in RoW by Region (2021-2030)
  • Table 32: Polymerase Chain Reaction Market in Middle East (2021-2030)
  • Table 33: Polymerase Chain Reaction Market in Africa (2021-2030)
  • Table 34: Polymerase Chain Reaction Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Polymerase Chain Reaction Market
  • Figure 3: Polymerase Chain Reaction Market in Global (2021-2030)
  • Figure 4: Polymerase Chain Reaction Market in Global by Type (2021-2030)
  • Figure 5: Polymerase Chain Reaction Market in Global by Application(2021-2030)
  • Figure 6: Polymerase Chain Reaction Market in Global by End User (2021-2030)
  • Figure 7: Polymerase Chain Reaction Market in Global by Geography (2021-2030)
  • Figure 8: Polymerase Chain Reaction Market in North America (2021-2030)
  • Figure 9: Polymerase Chain Reaction Market in North America by Country (2021-2030)
  • Figure 10: Polymerase Chain Reaction Market in the US (2021-2030)
  • Figure 11: Polymerase Chain Reaction Market in Canada (2021-2030)
  • Figure 12: Polymerase Chain Reaction Market in Mexico (2021-2030)
  • Figure 13: Polymerase Chain Reaction Market in Europe (2021-2030)
  • Figure 14: Polymerase Chain Reaction Market in Europe by Country (2021-2030)
  • Figure 15: Polymerase Chain Reaction Market in France (2021-2030)
  • Figure 16: Polymerase Chain Reaction Market in Germany (2021-2030)
  • Figure 17: Polymerase Chain Reaction Market in the United Kingdom (2021-2030)
  • Figure 18: Polymerase Chain Reaction Market in Italy (2021-2030)
  • Figure 19: Polymerase Chain Reaction Market in Spain (2021-2030)
  • Figure 20: Polymerase Chain Reaction Market in Russia (2021-2030)
  • Figure 21: Polymerase Chain Reaction Market in Rest of Europe (2021-2030)
  • Figure 22: Polymerase Chain Reaction Market in APAC (2021-2030)
  • Figure 23: Polymerase Chain Reaction Market in APAC by Country (2021-2030)
  • Figure 24: Polymerase Chain Reaction Market in China (2021-2030)
  • Figure 25: Polymerase Chain Reaction Market in Japan (2021-2030)
  • Figure 26: Polymerase Chain Reaction Market in India (2021-2030)
  • Figure 27: Polymerase Chain Reaction Market in Australia (2021-2030)
  • Figure 28: Polymerase Chain Reaction Market in South Korea (2021-2030)
  • Figure 29: Polymerase Chain Reaction Market in Rest of APAC (2021-2030)
  • Figure 30: Polymerase Chain Reaction Market in Rest of World (2021-2030)
  • Figure 31: Polymerase Chain Reaction Market in RoW by Region (2021-2030)
  • Figure 32: Polymerase Chain Reaction Market in Middle East (2021-2030)
  • Figure 33: Polymerase Chain Reaction Market in Africa (2021-2030)
  • Figure 34: Polymerase Chain Reaction Market in South America (2021-2030)
  • Figure 35: Polymerase Chain Reaction Market Drivers
  • Figure 36: Polymerase Chain Reaction Market Barriers
  • Figure 37: Polymerase Chain Reaction Marker Opportunities
  • Figure 38: PORTER'S Five Force Analysis